{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:33:28Z","timestamp":1761237208232},"reference-count":265,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1983,7,1]],"date-time":"1983-07-01T00:00:00Z","timestamp":425865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1983,7]]},"DOI":"10.1007\/bf01299927","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T12:02:14Z","timestamp":1111752134000},"page":"651-666","source":"Crossref","is-referenced-by-count":53,"title":["Drug effects on the liver"],"prefix":"10.1007","volume":"28","author":[{"given":"Jurgen","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Axelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/BF01317213","volume":"24","author":"J Ludwig","year":"1979","unstructured":"Ludwig J: Drug effects on the liver: A tabular compilation of drugs and drug-related hepatic diseases. Dig Dis Sci 24:785?796, 1979","journal-title":"Dig Dis Sci"},{"key":"CR2","unstructured":"Physicians' Desk Reference, 37th ed. Oradell, New Jersey, Medical Economics Co., 1983"},{"key":"CR3","unstructured":"Science Citation Index. Philadelphia, Institute for Scientific Information"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM198211183072107","volume":"307","author":"JM Wright","year":"1982","unstructured":"Wright JM, Stokes EF, Sweeney VP: Isoniazid-induced carbamazepine toxicity and vice versa. A double drug interaction. N Engl J Med 307:1325?1327, 1982","journal-title":"N Engl J Med"},{"key":"CR5","first-page":"233","volume-title":"Progress in Surgical Pathology, Vol 3","author":"H Popper","year":"1981","unstructured":"Popper H, Geller SA: Pathogenetic considerations in the histologic diagnosis of drug-induced liver injury.In Progress in Surgical Pathology, Vol 3. CM Fenoglio, M Wolff (eds.). New York, Masson Publishing, 1981, pp 233?246"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2008-1040722","volume":"1","author":"HJ Zimmerman","year":"1981","unstructured":"Zimmerman HJ: Drug-induced liver disease: An overview. Semin Liver Dis 1:93?103, 1981","journal-title":"Semin Liver Dis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF01296760","volume":"27","author":"M Black","year":"1982","unstructured":"Black M, Cornell JF, Rabin L, Shachter, N: Late presentation of acetaminophen hepatotoxicity. Dig Dis Sci 27:370?374, 1982","journal-title":"Dig Dis Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(82)92801-X","volume":"2","author":"DNK Symon","year":"1982","unstructured":"Symon DNK, Gray ES, Hanmer OJ, Russell G: Fatal paracetamol poisoning from benorylate therapy in child with cystic fibrosis. Lancet 2:1153?1154, 1982 (letter)","journal-title":"Lancet"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(78)90740-7","volume":"1","author":"HL Bonkowsky","year":"1978","unstructured":"Bonkowsky HL, Mudge GH, McMurtry RJ: Chronic hepatic inflammation and fibrosis due to low doses of paracetamol. Lancet 1:1016?1018, 1978","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0046-8177(80)80103-1","volume":"11","author":"MA Gerber","year":"1980","unstructured":"Gerber MA, Kaufmann H, Klion F, Alpert LI: Acetaminophen associated hepatic injury. Report of two cases showing unusual portal tract reactions. Hum Pathol 11:37?42, 1980","journal-title":"Hum Pathol"},{"key":"CR11","first-page":"273","volume":"73","author":"Y Arthurs","year":"1980","unstructured":"Arthurs Y, Fielding JF: Paracetamol and chronic liver disease. J Ir Med Assoc 73:273?274, 1980","journal-title":"J Ir Med Assoc"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-87-3-302","volume":"87","author":"GK Johnson","year":"1977","unstructured":"Johnson GK, Tolman KG: Chronic liver disease and acetaminophen. Ann Intern Med 87:302?304, 1977","journal-title":"Ann Intern Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJM196607142750210","volume":"275","author":"MJ Goldstein","year":"1966","unstructured":"Goldstein MJ, Rothenberg AJ: Jaundice in a patient receiving acetohexamide. N Engl J Med 275:97?99, 1966","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/1097-0142(197912)44:6<2324::AID-CNCR2820440648>3.0.CO;2-8","volume":"44","author":"AN Houghton","year":"1979","unstructured":"Houghton AN, Shafi, N, Rickles FR: Acute hepatic vein thrombosis occurring during therapy for Hodgkin's disease. A case report. Cancer 44:2324?2329, 1979","journal-title":"Cancer"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-95-5-588","volume":"95","author":"FH Al-Kawas","year":"1981","unstructured":"Al-Kawas FH, Seeff LB, Berendson RA, Zimmerman HJ, Ishak KG: Allopurinol hepatotoxicity. Report of two cases and review of the literature. Ann Intern Med 95:588?590, 1981","journal-title":"Ann Intern Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jama.1977.03270320051024","volume":"237","author":"RC Butler","year":"1977","unstructured":"Butler RC, Shah SM, Grunow WA, Texter EC Jr: Massive hepatic necrosis in a patient receiving allopurinol. JAMA 237:473?474, 1977","journal-title":"JAMA"},{"key":"CR17","first-page":"604","volume-title":"Diseases of the Liver","author":"G Klatskin","year":"1975","unstructured":"Klatskin G: Toxic and drug-induced hepatitis.In Diseases of the Liver, 4th ed. L. Schiff (ed.). Philadelphia, JB Lippincott, 1975, pp 604?710","edition":"4th ed."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/00007611-197911000-00004","volume":"72","author":"PG Lang Jr","year":"1979","unstructured":"Lang PG Jr: Severe hypersensitivity reactions to allopurinol. South Med J 72:1361?1368, 1979","journal-title":"South Med J"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/bmj.1.6123.1320","volume":"1","author":"A Medline","year":"1978","unstructured":"Medline A, Cohen LB, Tobe BA, Sellers EM: Liver granulomas and allopurinol. Br Med J 1:1320?1321, 1978","journal-title":"Br Med J"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archinte.1965.03860140008003","volume":"115","author":"H Popper","year":"1965","unstructured":"Popper H, Rubin E, Gardiol D, Schaffner F, Paronetto F: Drug-induced liver disease. A penalty for progress. Arch Intern Med 115:128?136, 1965","journal-title":"Arch Intern Med"},{"key":"CR21","first-page":"460","volume-title":"Laboratory Diagnosis of Diseases Caused by Toxic Agents","author":"G Kent","year":"1970","unstructured":"Kent G, Orfei E: Hepatic manifestations of toxic and therapeutic agents.In Laboratory Diagnosis of Diseases Caused by Toxic Agents. FW Sunderman, FW Sunderman Jr (eds.). St. Louis, Warren H. Green, 1970, pp 460?468"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9343(60)90026-7","volume":"29","author":"DG Simpson","year":"1960","unstructured":"Simpson DG, Walker JH: Hypersensitivity to para-aminosalicylic acid. Am J Med 29:297?306, 1960","journal-title":"Am J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1192\/bjp.111.480.1107","volume":"111","author":"ML Cunningham","year":"1965","unstructured":"Cunningham ML: Acute hepatic necrosis following treatment with amitriptyline and diazepam. Br J Psychiatry 111:1107?1109, 1965","journal-title":"Br J Psychiatry"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.1975.03250080035013","volume":"232","author":"J Yon","year":"1975","unstructured":"Yon J, Anuras S: Hepatitis caused by amitriptyline therapy. JAMA 232:833?834, 1975","journal-title":"JAMA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1192\/bjp.113.503.1113","volume":"113","author":"RW Biagi","year":"1967","unstructured":"Biagi RW, Bapat BN: Intrahepatic obstructive jaundice from amitriptyline. Br J Psychiatry 113:1113?1114, 1967","journal-title":"Br J Psychiatry"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-89-3-359","volume":"89","author":"HF Herlong","year":"1978","unstructured":"Herlong HF, Reid PR, Boitnott JK, Maddrey WC: Aprindine hepatitis. Ann Intern Med 89:359?361, 1978","journal-title":"Ann Intern Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oxfordjournals.eurheartj.a061109","volume":"1","author":"I Stoel","year":"1980","unstructured":"Stoel I, Hagemeijer F: Aprindine: A review. Eur Heart J 1:147?156, 1980","journal-title":"Eur Heart J"},{"issue":"Suppl 4","key":"CR28","first-page":"57","volume":"65","author":"CM Haskell","year":"1981","unstructured":"Haskell CM:l-Asparaginase: Human toxicology and single agent activity in nonleukemic neoplasms. Cancer Treat Rep 65(Suppl 4):57?59, 1981","journal-title":"Cancer Treat Rep"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-80-1-1","volume":"80","author":"WE Seaman","year":"1974","unstructured":"Seaman WE, Ishak KG, Plotz PH: Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med 80:1?8, 1974","journal-title":"Ann Intern Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-86-2-183","volume":"86","author":"JA Sbarbaro","year":"1977","unstructured":"Sbarbaro JA, Bennett RM: Aspirin hepatotoxicity and disseminated intravascular coagulation. Ann Intern Med 86:183?185, 1977","journal-title":"Ann Intern Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.1981.00340030065013","volume":"141","author":"HJ Zimmerman","year":"1981","unstructured":"Zimmerman HJ: Effects of aspirin and acetaminophen on the liver. Arch Intern Med 141:333?342, 1981","journal-title":"Arch Intern Med"},{"key":"CR32","first-page":"61","volume":"44","author":"KR McMaster III","year":"1981","unstructured":"McMaster KR III, Hennigar GR: Drug-induced granulomatous hepatitis. Lab Invest 44:61?73, 1981","journal-title":"Lab Invest"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.1982.03330060027028","volume":"248","author":"TJ Halpin","year":"1982","unstructured":"Halpin TJ, Holtzhauer FJ, Campbell RJ, Hall LJ, Correa-Villase\u00f1or A, Lanese R, Rice J, Hurwitz ES: Reye's syndrome and medication use. JAMA 248:687?691, 1982","journal-title":"JAMA"},{"key":"CR34","first-page":"289","volume":"31","author":"CDC","year":"1982","unstructured":"CDC. Surgeon General's advisory on the use of salicylates and Reye syndrome. Morbidity and Mortality Weekly Report 31:289?290, 1982","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"CR35","first-page":"563","volume":"66","author":"BA Peterson","year":"1982","unstructured":"Peterson BA, Bloomfield CD, Gottlieb AJ, Coleman M, Greenberg MS: 5-Azacitidine and zorubicin for patients with previously treated acute nonlymphocytic leukemia: A cancer and leukemia group B pilot study. Cancer Treat Rep 66:563?566, 1982","journal-title":"Cancer Treat Rep"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.1972.03210060044010","volume":"222","author":"Z Zarday","year":"1972","unstructured":"Zarday Z, Veith FJ, Gliedman ML, Soberman R: Irreversible liver damage after azathioprine. JAMA 222:690?691, 1972","journal-title":"JAMA"},{"key":"CR37","first-page":"1576","volume":"103","author":"J Haas","year":"1978","unstructured":"Haas J, Patzold U, Stamm T: Intrahepatische Cholestase, eine allergische Reaktion bei Azathioprin-Therapie. Dtsch Med Wochenschr 103:1576?1577, 1978","journal-title":"Dtsch Med Wochenschr"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00429351","volume":"395","author":"H Weitz","year":"1982","unstructured":"Weitz H, Gokel JM, Loeschke K, Possinger K, Eder M: Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch (Pathol Anat) 395:245?256, 1982","journal-title":"Virchows Arch (Pathol Anat)"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0016-5085(19)32476-X","volume":"69","author":"AT Marubbio","year":"1975","unstructured":"Marubbio AT, Danielson B: Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine. Gastroenterology 69:739?743, 1975","journal-title":"Gastroenterology"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.19.8.748","volume":"19","author":"C Degott","year":"1978","unstructured":"Degott C, Rueff B, Kreis H, Duboust A, Potet F, Benhamou JP: Peliosis hepatis in recipients of renal transplants. Gut 19:748?753, 1978","journal-title":"Gut"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3476(77)80529-5","volume":"91","author":"P Zucker","year":"1977","unstructured":"Zucker P, Daum F, Cohen MI: Fatal carbamazepine hepatitis. J Pediatr 91:667?668, 1977","journal-title":"J Pediatr"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.0954-6820.1981.tb09826.x","volume":"210","author":"G Hopen","year":"1981","unstructured":"Hopen G, Nesthus I, Laerum OD: Fatal carbamazepine-associated hepatitis. Report of two cases. Acta Med Scand 210:333?335, 1981","journal-title":"Acta Med Scand"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.4.5572.155","volume":"4","author":"ID Ramsay","year":"1967","unstructured":"Ramsay ID: Carbamazepine-induced jaundice. Br Med J 4:155, 1967","journal-title":"Br Med J"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7326\/0003-4819-95-1-64","volume":"95","author":"M Levy","year":"1981","unstructured":"Levy M, Goodman MW, Van Dyne BJ, Sumner HW: Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 95:64?65, 1981","journal-title":"Ann Intern Med"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9343(81)90244-8","volume":"71","author":"MC Mitchell","year":"1981","unstructured":"Mitchell MC, Boitnott JK, Arregui A, Maddrey WC: Granulomatous hepatitis associated with carbamazepine therapy. Am J Med 71:733?735, 1981","journal-title":"Am J Med"},{"key":"CR46","first-page":"221","volume":"15","author":"F Schaffner","year":"1969","unstructured":"Schaffner F, Raisfeld IH: Drugs and the liver: A review of metabolism and adverse reactions. Adv Intern Med 15:221?251, 1969","journal-title":"Adv Intern Med"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/jama.1975.03250080020009","volume":"232","author":"FM Wilson","year":"1975","unstructured":"Wilson FM, Belamaric J, Lauter CB, Lerner AM: Anicteric carbenicillin hepatitis. Eight episodes in four patients. JAMA 232:818?821, 1975","journal-title":"JAMA"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ajcp\/75.4.614","volume":"75","author":"RE McIntyre","year":"1981","unstructured":"McIntyre RE, Magidson JG, Austin GE, Gale RP, Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and autologous bone marrow transplantation. Am J Clin Pathol 75:614?617, 1981","journal-title":"Am J Clin Pathol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(82)90311-7","volume":"2","author":"R Ammann","year":"1982","unstructured":"Ammann R, Neftel K, Hardmeier TH, Reinhardt M: Cephalosporin-induced cholestatic jaundice. Lancet 2:336?337, 1982 (letter)","journal-title":"Lancet"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01072185","volume":"22","author":"MC Bateson","year":"1977","unstructured":"Bateson MC, Hopwood D, Bouchier IAD: Effect of gallstone-dissolution therapy on human liver structure. Am J Dig Dis 22:293?299, 1977","journal-title":"Am J Dig Dis"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hep.1840020202","volume":"2","author":"RL Fisher","year":"1982","unstructured":"Fisher RL, Anderson DW, Boyer JL, Ishak K, Klatskin G, Lachin JM, Phillips MJ, and the Steering Committee for the National Cooperative Gallstone Study Group: A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis: The National Cooperative Gallstone Study. Hepatology 2:187?201, 1982","journal-title":"Hepatology"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0016-5085(62)80049-3","volume":"42","author":"GD Amromin","year":"1962","unstructured":"Amromin GD, Deliman RM, Shanbrom E: Liver damage after chemotherapy for leukemia and lymphoma. Gastroenterology 42:401?410, 1962","journal-title":"Gastroenterology"},{"key":"CR53","first-page":"1449","volume":"274","author":"D Pickering","year":"1966","unstructured":"Pickering D: Hepatic necrosis after chlordiazepoxide therapy. N Engl J Med 274:1449, 1966 (letter)","journal-title":"N Engl J Med"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM196508052730608","volume":"273","author":"A Abbruzzese","year":"1965","unstructured":"Abbruzzese A, Swanson J: Jaundice after therapy with chlordiazepoxide hydrochloride. N Engl J Med 273:321?322, 1965","journal-title":"N Engl J Med"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02239339","volume":"9","author":"KO Husebye","year":"1964","unstructured":"Husebye, KO: Jaundice with persisting pericholangiolitic inflammation in a patient treated with chlorothiazide. Report of a case. Am J Dig Dis 9:439?446, 1964","journal-title":"Am J Dig Dis"},{"key":"CR56","first-page":"1235","volume":"64","author":"RJ Belt","year":"1980","unstructured":"Belt RJ, McGregor D, Haas CD, Bhatia PS: Cholestatic jaundice associated with chlorozotocin. Cancer Treat Rep 64:1235?1239, 1980","journal-title":"Cancer Treat Rep"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.1.5854.655","volume":"1","author":"RI Russell","year":"1973","unstructured":"Russell RI, Allan JG, Patrick R: Active chronic hepatitis after chlorpromazine ingestion. Br Med J 1:655?656, 1973","journal-title":"Br Med J"},{"key":"CR58","first-page":"283","volume":"93","author":"KG Ishak","year":"1972","unstructured":"Ishak KG, Irey NS: Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. Arch Pathol 93:283?304, 1972","journal-title":"Arch Pathol"},{"key":"CR59","first-page":"131","volume":"1","author":"SK Irani","year":"1979","unstructured":"Irani SK, Dobbins WO III: Hepatic granulomas: A review of 73 patients from one hospital and survey of the literature. J Clin Gastroenterol 1:131?143, 1979","journal-title":"J Clin Gastroenterol"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9343(60)90161-3","volume":"28","author":"J Reichel","year":"1960","unstructured":"Reichel J, Goldberg SB, Ellenberg M, Schaffner F: Intrahepatic cholestasis following administration of chlorpropamide. Report of a case with electron microscopic observations. Am J Med 28:654?660, 1960","journal-title":"Am J Med"},{"key":"CR61","first-page":"1","volume":"3","author":"JC Bateman","year":"1953","unstructured":"Bateman JC, Barberio JR, Cromer JK, Klopp CT: Investigation of mechanism and type of jaundice produced by large doses of parenterally administered aureomycin. Antibiot Chemother 3:1?15, 1953","journal-title":"Antibiot Chemother"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0016-5085(51)80131-8","volume":"18","author":"VM Sborov","year":"1951","unstructured":"Sborov VM, Sutherland DA: Fatty liver following aureomycin and terramycin therapy in chronic hepatic disease. Gastroenterology 18:598?605, 1951","journal-title":"Gastroenterology"},{"key":"CR63","first-page":"267","volume":"74","author":"L Ruiz Del Arbol","year":"1980","unstructured":"Ruiz Del Arbol L, Moreira V, Moreno A, Hern\u00e1ndez Ranz F, Cano A, Garc\u00eda Plaza A: Bridging hepatic necrosis associated with cimetidine. Am J Gastroenterol 74:267?269, 1980","journal-title":"Am J Gastroenterol"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01391643","volume":"26","author":"I Lorenzini","year":"1981","unstructured":"Lorenzini I, Jezequel AM, Orlandi F: Cimetidine-induced hepatitis. Electron microscopic observations and clinical pattern of liver injury. Dig Dis Sci 26:275?280, 1981","journal-title":"Dig Dis Sci"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004836-198103000-00017","volume":"3","author":"HC Bodenheimer Jr","year":"1981","unstructured":"Bodenheimer HC Jr, Thayer WR Jr: Hemochromatosis associated with chronic cimetidine therapy? J Clin Gastroenterol 3:83?85, 1981","journal-title":"J Clin Gastroenterol"},{"key":"CR66","first-page":"2125","volume":"62","author":"F Cavalli","year":"1978","unstructured":"Cavalli F, Tschopp L, Sonntag RW, Zimmermann A: A case of liver toxicity followingcis-dichlorodiammineplatinum(II) treatment. Cancer Treat Rep 62:2125?2126, 1978 (letter)","journal-title":"Cancer Treat Rep"},{"key":"CR67","first-page":"671","volume":"32","author":"H Mori","year":"1982","unstructured":"Mori H, Tanaka T, Sugie S, Takahashi M: Adenoma with multiple hyperplastic nodules in noncirrhotic liver possibly related to long-term administration of a hypolipidemic drug. Acta Pathol Jpn 32:671?675, 1982","journal-title":"Acta Pathol Jpn"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000198597","volume":"22","author":"D Pessayre","year":"1981","unstructured":"Pessayre D, Degos F, Feldmann G, Degott C, Bernuau J, Benhamou J-P: Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin. Digestion 22:66?72, 1981","journal-title":"Digestion"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/pgmj.55.650.908","volume":"55","author":"JLW Parker","year":"1979","unstructured":"Parker JLW: Potassium clorazepate (Tranxene)-induced jaundice. Postgrad Med J 55:908?910, 1979","journal-title":"Postgrad Med J"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0016-5085(80)90928-2","volume":"79","author":"ES Zafrani","year":"1980","unstructured":"Zafrani ES, Pinaudeau Y, Le Cudonnec B, Julien M, Dhumeaux D: Focal hemorrhagic necrosis of the liver. A clinicopathological entity possibly related to oral contraceptives. Gastroenterology 79:1295?1299, 1980","journal-title":"Gastroenterology"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2008-1040724","volume":"1","author":"KG Ishak","year":"1981","unstructured":"Ishak KG: Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis 1:116?128, 1981","journal-title":"Semin Liver Dis"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(81)90145-1","volume":"80","author":"M Camilleri","year":"1981","unstructured":"Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K: Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 80:810?815, 1981","journal-title":"Gastroenterology"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0046-8177(76)80082-2","volume":"7","author":"LI Alpert","year":"1976","unstructured":"Alpert LI: Veno-occlusive disease of the liver associated with oral contraceptives: Case report and review of literature. Hum Pathol 7:709?718, 1976","journal-title":"Hum Pathol"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/0016-5085(82)90083-X","volume":"82","author":"G Lalonde","year":"1982","unstructured":"Lalonde G, Th\u00e9oret G, Daloze P, Bettez P, Katz SS: Inferior vena cava stenosis and Budd-Chiari syndrome in a woman taking oral contraceptives. Gastroenterology 82:1452?1456, 1982","journal-title":"Gastroenterology"},{"key":"CR75","first-page":"504","volume":"77","author":"TS Helling","year":"1982","unstructured":"Helling TS, Wood WG: Oral contraceptives and cancer of the liver: A review of two additional cases. Am J Gastroenterol 77:504?508, 1982","journal-title":"Am J Gastroenterol"},{"key":"CR76","first-page":"187","volume":"29","author":"K Horri","year":"1982","unstructured":"Horri K, Yasui M, Adachi Y, Yamamoto T, Ishida O, Itoh H: An autopsy case of primary hepatoma associated with an oral contraceptive. Hepato-Gastroenterol 29:187?190, 1982","journal-title":"Hepato-Gastroenterol"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0140-6736(80)90804-1","volume":"1","author":"ER Littlewood","year":"1980","unstructured":"Littlewood ER, Barrison IG, Murray-Lyon IM, Paradinas FJ: Cholangiocarcinoma and oral contraceptives. Lancet 1:310?311, 1980","journal-title":"Lancet"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000478-197904000-00011","volume":"3","author":"L Ladaga","year":"1979","unstructured":"Ladaga, L, Kay S, Melcher M, King JN: Combined epithelial and sarcomatous elements in a liver cancer associated with oral contraceptive use. Am J Surg Pathol 3:185?190, 1979","journal-title":"Am J Surg Pathol"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.1981.03320010044029","volume":"246","author":"PS Monroe","year":"1981","unstructured":"Monroe PS, Riddell RH, Siegler M, Baker AL: Hepatic angiosarcoma. Possible relationship to long-term oral contraceptive ingestion. JAMA 246:64?65, 1981","journal-title":"JAMA"},{"key":"CR80","first-page":"244","volume":"106","author":"DA Malatjalian","year":"1982","unstructured":"Malatjalian DA, Graham CH: Liver adenoma with granulomas. The appearance of granulomas in oral contraceptive-related hepatocellular adenoma and in the surrounding nontumorous liver. Arch Pathol Lab Med 106:244?246, 1982","journal-title":"Arch Pathol Lab Med"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0016-5085(82)90327-4","volume":"82","author":"H B\u00fchler","year":"1982","unstructured":"B\u00fchler H, Pirovino M, Akovbiantz A, Altorfer J, Weitzel M, Maranta E, Schmid M: Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 82:775?782, 1982","journal-title":"Gastroenterology"},{"key":"CR82","first-page":"435","volume":"27","author":"I Bart\u00f3k","year":"1980","unstructured":"Bart\u00f3k I, Decastello A, Csik\u00f3s F, Nagy I: Focal nodular hyperplasia of the liver and hepatic cell adenoma in women on oral contraceptives. Hepato-Gastroenterol 27:435?440, 1980","journal-title":"Hepato-Gastroenterol"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0016-5085(52)80016-2","volume":"21","author":"H Steinberg","year":"1952","unstructured":"Steinberg H, Webb WM, Rafsky HA: Hepatomegaly with fatty infiltration, secondary to cortisone therapy: Case report. Gastroenterology 21:304?309, 1952","journal-title":"Gastroenterology"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0046-8177(78)80090-2","volume":"9","author":"JB Taxy","year":"1978","unstructured":"Taxy JB: Peliosis: A morphologic curiosity becomes an iatrogenic problem. Hum Pathol 9:331?340, 1978","journal-title":"Hum Pathol"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.1978.03630310071022","volume":"138","author":"JL Rosenberg","year":"1978","unstructured":"Rosenberg JL, Edlow D, Sneider R: Liver disease and vasculitis in a patient taking cromolyn. Arch Intern Med 138:989?991, 1978","journal-title":"Arch Intern Med"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007890-198112000-00007","volume":"32","author":"GBG Klintmalm","year":"1981","unstructured":"Klintmalm GBG, Iwatsuki S, Starzl TE: Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 32:488?489, 1981","journal-title":"Transplantation"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(80)90368-X","volume":"68","author":"WG Woods","year":"1980","unstructured":"Woods WG, Dehner LP, Nesbit ME, Krivit W, Coccia PF, Ramsay NKC, Kim TH, Kersey JH: Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation. Am J Med 68:285?290, 1980","journal-title":"Am J Med"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00410649","volume":"95","author":"PJ Frosch","year":"1979","unstructured":"Frosch PJ, Czarnetzki BM, Macher E, Grundmann E, Gottschalk I: Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma. J Cancer Res Clin Oncol 95:281?286, 1979","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2008-1070640","volume":"105","author":"U Runne","year":"1980","unstructured":"Runne U, Doepfmer K, Antz H, Groth W, F\u00e9aux de Lacroix W: Budd-Chiari-Syndrom unter Dacarbazin. Dtsch Med Wochenschr 105:230?233, 1980","journal-title":"Dtsch Med Wochenschr"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7326\/0003-4819-84-3-290","volume":"84","author":"KG Tolman","year":"1976","unstructured":"Tolman KG, Hammar S, Sannella JJ: Possible hepatotoxicity of Doxidan. Ann Intern Med 84:290?292, 1976","journal-title":"Ann Intern Med"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.20.1.33","volume":"20","author":"SP Wilkinson","year":"1979","unstructured":"Wilkinson SP, Portmann B, Williams R: Hepatitis from dantrolene sodium. Gut 20:33?36, 1979","journal-title":"Gut"},{"key":"CR92","first-page":"336","volume":"80","author":"M Cornette","year":"1980","unstructured":"Cornette M, Gillard C, Borlee-Hermans G: H\u00e9patite toxique mortelle associ\u00e9e \u00e0 l'usage du dantrol\u00e8ne. Acta Neurol Belg 80:336?347, 1980","journal-title":"Acta Neurol Belg"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0016-5085(77)80141-8","volume":"72","author":"R Utili","year":"1977","unstructured":"Utili R, Boitnott JK, Zimmerman HJ: Dantrolene-associated hepatic injury. Gastroenterology 72:610?616, 1977","journal-title":"Gastroenterology"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-84-1-53","volume":"84","author":"RM Ogburn","year":"1976","unstructured":"Ogburn RM, Myers RL, Burdick GE: Hepatitis associated with dantrolene sodium. Ann Intern Med 84:53?54, 1976 (letter)","journal-title":"Ann Intern Med"},{"key":"CR95","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.1976.03260410046023","volume":"235","author":"R Schneider","year":"1976","unstructured":"Schneider R, Mitchell D: Dantrolene hepatitis. JAMA 235:1590?1591, 1976","journal-title":"JAMA"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-87-2-247_2","volume":"87","author":"JS Penta","year":"1977","unstructured":"Penta JS, Von Hoff DD, Muggia FM: Hepatotoxicity of combination chemotherapy for acute myelocytic leukemia. Ann Intern Med 87:247, 1977 (letter)","journal-title":"Ann Intern Med"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.1968.03150030098027","volume":"206","author":"WJ Powell Jr","year":"1968","unstructured":"Powell WJ Jr, Koch-Weser J, Williams RA: Lethal hepatic necrosis after therapy with imipramine and desipramine. JAMA 206:642?644, 1968","journal-title":"JAMA"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00325481.1979.11715157","volume":"65","author":"AR Puppala","year":"1979","unstructured":"Puppala AR, Ro JA: Possible association between peliosis hepatis and diethylstilbestrol. Report of two cases. Postgrad Med 65:277?281, 1979","journal-title":"Postgrad Med"},{"key":"CR99","first-page":"1139","volume":"111","author":"V Rosinus","year":"1981","unstructured":"Rosinus V, Maurer R: Di\u00e4thylstilb\u00f6strol-induziertes Leberzellkarzinom? Schweiz Med Wochenschr 111:1139?1142, 1981","journal-title":"Schweiz Med Wochenschr"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.1978.03290140052023","volume":"240","author":"C Hoch-Ligeti","year":"1978","unstructured":"Hoch-Ligeti C: Angiosarcoma of the liver associated with diethylstilbestrol. JAMA 240:1510?1511, 1978","journal-title":"JAMA"},{"key":"CR101","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/BF01338532","volume":"25","author":"JM Ham","year":"1980","unstructured":"Ham JM, Pirola RC, Crouch RL: Hemangioendothelial sarcoma of the liver associated with long-term estrogen therapy in a man. Dig Dis Sci 25:879?883, 1980","journal-title":"Dig Dis Sci"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00007611-198204000-00036","volume":"75","author":"PT Doody","year":"1978","unstructured":"Doody PT: Disopyramide hepatotoxicity and disseminated intravascular coagulation. South Med J 75:496?498, 1978","journal-title":"South Med J"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0140-6736(77)90768-1","volume":"2","author":"T Meinertz","year":"1977","unstructured":"Meinertz T, Langer KH, Kasper W, Just H: Disopyramide-induced intrahepatic cholestasis. Lancet 2:828?829, 1977 (letter)","journal-title":"Lancet"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0016-5085(78)93772-1","volume":"75","author":"SJ Morris","year":"1978","unstructured":"Morris SJ, Kanner R, Chiprut RO, Schiff ER: Disulfiram hepatitis. Gastroenterology 75:100?102, 1978","journal-title":"Gastroenterology"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.1979.tb03019.x","volume":"3","author":"JJ V\u00e1zquez","year":"1979","unstructured":"V\u00e1zquez JJ, Pardo-Mindan J: Liver cell injury (bodies similar to Lafora's) in alcoholics treated with disulfiram (Antabuse). Histopathology 3:377?384, 1979","journal-title":"Histopathology"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF01313593","volume":"26","author":"LB White","year":"1981","unstructured":"White LB, DeTarnowsky GO, Mir JA, Layden TJ: Hepatotoxicity following enflurane anesthesia. Dig Dis Sci 26:466?469, 1981","journal-title":"Dig Dis Sci"},{"key":"CR107","first-page":"146","volume":"59","author":"FV Ona","year":"1980","unstructured":"Ona FV, Patanella H, Ayub A: Hepatitis associated with enflurane anesthesia. Anesth Analg 59:146?149, 1980","journal-title":"Anesth Analg"},{"key":"CR108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0016-5085(80)90085-2","volume":"79","author":"MM Kline","year":"1980","unstructured":"Kline MM: Enflurane-associated hepatitis. Gastroenterology 79:126?127, 1980","journal-title":"Gastroenterology"},{"key":"CR109","first-page":"320","volume":"132","author":"JD Lloyd-Still","year":"1978","unstructured":"Lloyd-Still JD, Sherman JO, Boggs J, Demers LM: Erythromycin estolate hepatotoxicity. Am J Dis Child 132:320, 1978","journal-title":"Am J Dis Child"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01297126","volume":"24","author":"ES Zafrani","year":"1979","unstructured":"Zafrani ES, Ishak KG, Rudzki C: Cholestatic and hepato-cellular injury associated with erythromycin esters. Report of nine cases. Dig Dis Sci 24:385?396, 1979","journal-title":"Dig Dis Sci"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.3.5558.152","volume":"3","author":"KK Datey","year":"1967","unstructured":"Datey KK, Deshmukh SN, Dalvi CP, Purandare NM: Hepatocellular damage with ethacrynic acid. Br Med J 3:152?153, 1967","journal-title":"Br Med J"},{"key":"CR112","first-page":"542","volume":"90","author":"HO Conn","year":"1964","unstructured":"Conn HO, Binder HJ, Orr HD: Ethionamide-induced hepatitis. A review with a report of an additional case. Am Rev Respir Dis 90:542?552, 1964","journal-title":"Am Rev Respir Dis"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1055\/s-0028-1106031","volume":"92","author":"E Kuntz","year":"1967","unstructured":"Kuntz E, Liehr H, Pfingst W: Toxische Lebersch\u00e4digung durch \u00c4thionamid. Dtsch Med Wochenschr 92:1718?1722, 1967","journal-title":"Dtsch Med Wochenschr"},{"key":"CR114","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0190-9622(82)70057-X","volume":"6","author":"SD Glazer","year":"1982","unstructured":"Glazer SD, Roenigk HH Jr, Yokoo H, Sparberg M: A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis. J Am Acad Dermatol 6:683?687, 1982","journal-title":"J Am Acad Dermatol"},{"key":"CR115","first-page":"100","volume":"89","author":"MS Wheby","year":"1977","unstructured":"Wheby MS: Medicinal iron-induced hepatic cirrhosis: Reversal by phlebotomy: Studies on pathogenesis. Trans Am Clin Climatol Assoc 89:100?108, 1977","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"CR116","first-page":"405","volume":"101","author":"J Nadell","year":"1977","unstructured":"Nadell J, Kosek J: Peliosis hepatis. Twelve cases associated with oral androgen therapy. Arch Pathol Lab Med 101:405?410, 1977","journal-title":"Arch Pathol Lab Med"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(79)92515-7","volume":"2","author":"H Falk","year":"1979","unstructured":"Falk H, Thomas LB, Popper H, Ishak KG: Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 2:1120?1123, 1979","journal-title":"Lancet"},{"key":"CR118","first-page":"336","volume":"73","author":"S Snyder","year":"1980","unstructured":"Snyder S: Fluphenazine jaundice. Report of a case. Am J Gastroenterol 73:336?340, 1980","journal-title":"Am J Gastroenterol"},{"key":"CR119","first-page":"893","volume":"124","author":"R Reynolds","year":"1981","unstructured":"Reynolds R, Lloyd DA, Slinger RP: Cholestatic jaundice induced by flurazepam hydrochloride. Can Med Assoc J 124:893?894, 1981","journal-title":"Can Med Assoc J"},{"key":"CR120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-89-3-363","volume":"89","author":"MH Fang","year":"1978","unstructured":"Fang MH, Ginsberg AL, Dobbins WO III Cholestatic jaundice associated with flurazepam hydrochloride. Ann Intern Med 89:363?364, 1978","journal-title":"Ann Intern Med"},{"key":"CR121","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0022-3476(78)81255-4","volume":"93","author":"FK Ghishan","year":"1978","unstructured":"Ghishan FK, LaBrecque DR, Younoszai K: Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis. J Pediatr 93:1042?1043, 1978","journal-title":"J Pediatr"},{"key":"CR122","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/rheumatology\/18.3.174","volume":"18","author":"AJ Griffin","year":"1979","unstructured":"Griffin AJ: Cholestatic hepatitis induced by gold. Rheumatol Rehabil 18:174?176, 1979","journal-title":"Rheumatol Rehabil"},{"key":"CR123","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0016-5085(76)80327-7","volume":"70","author":"RO Chiprut","year":"1976","unstructured":"Chiprut RO, Viteri A, Jamroz C, Dyck WP: Intrahepatic cholestasis after griseofulvin administration. Gastroenterology 70:1141?1143, 1976","journal-title":"Gastroenterology"},{"key":"CR124","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0016-5085(82)80209-6","volume":"83","author":"HP Dincsoy","year":"1982","unstructured":"Dincsoy HP, Saelinger DA: Haloperidol-induced chronic cholestatic liver disease. Gastroenterology 83:694?700, 1982","journal-title":"Gastroenterology"},{"key":"CR125","first-page":"467","volume":"145","author":"MS H\u00fcttel","year":"1979","unstructured":"H\u00fcttel MS: Halothane hepatitis after jejunoileal bypass. Acta Chir Scand 145:467?469, 1979","journal-title":"Acta Chir Scand"},{"key":"CR126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2008-1040726","volume":"1","author":"J Touloukian","year":"1981","unstructured":"Touloukian J, Kaplowitz N: Halothane-induced hepatic disease. Semin Liver Dis 1:134?142, 1981","journal-title":"Semin Liver Dis"},{"key":"CR127","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-81-4-487","volume":"81","author":"FB Thomas","year":"1974","unstructured":"Thomas FB: Chronic aggressive hepatitis induced by halothane. Ann Intern Med 81:487?489, 1974","journal-title":"Ann Intern Med"},{"key":"CR128","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM196903062801001","volume":"280","author":"G Klatskin","year":"1969","unstructured":"Klatskin G, Kimberg DV: Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med 280:515?522, 1969","journal-title":"N Engl J Med"},{"key":"CR129","first-page":"431","volume":"59","author":"PL Gigase","year":"1979","unstructured":"Gigase PL, Mortelmans J, Van Marck EAE: N\u00e9crose h\u00e9patique mortelle apr\u00e8s administration d'hycanthone. Ann Soc Belg Med Trop 59:431?434, 1979","journal-title":"Ann Soc Belg Med Trop"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0016-5085(78)93773-3","volume":"75","author":"C Cohen","year":"1978","unstructured":"Cohen C: Liver pathology in hycanthone hepatitis. Gastroenterology 75:103?106, 1978","journal-title":"Gastroenterology"},{"key":"CR131","first-page":"13","volume":"28","author":"S Itoh","year":"1981","unstructured":"Itoh S, Ichinoe A, Tsukada Y, Itoh Y: Hydralazine-induced hepatitis. Hepato-Gastroenterol 28:13?16, 1981","journal-title":"Hepato-Gastroenterol"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/BF01338533","volume":"25","author":"S Itoh","year":"1980","unstructured":"Itoh S, Yamaba Y, Ichinoe A, Tsukada Y: Hydralazine-induced liver injury. Dig Dis Sci 25:884?887, 1980","journal-title":"Dig Dis Sci"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/archinte.1979.03630430074024","volume":"139","author":"E Bartoli","year":"1979","unstructured":"Bartoli E, Massarelli G, Solinas A, Faedda R, Chiandussi L: Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case. Arch Intern Med 139:698?699, 1979","journal-title":"Arch Intern Med"},{"key":"CR134","first-page":"476","volume":"4","author":"MS A\u00f1ez","year":"1981","unstructured":"A\u00f1ez MS, Dickson G, Zabala R, Zabaleta P, Pacheco A, Brice\u00f1o D: Hepatitis aguda por hidroclorotiacida. Presentaci\u00f3n de un caso. Gastroenterol Hepatol 4:476?478, 1981","journal-title":"Gastroenterol Hepatol"},{"key":"CR135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-87-2-200","volume":"87","author":"JF Bravo","year":"1977","unstructured":"Bravo JF, Jacobson MP, Mertens BF: Fatty liver and pleural effusion with ibuprofen therapy. Ann Intern Med 87:200?201, 1977","journal-title":"Ann Intern Med"},{"key":"CR136","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0016-5085(80)90383-2","volume":"79","author":"DA Horst","year":"1980","unstructured":"Horst DA, Grace ND, LeCompte PM: Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy. Gastroenterology 79:550?554, 1980","journal-title":"Gastroenterology"},{"key":"CR137","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jama.1967.03120080120029","volume":"199","author":"WM Kelsey","year":"1967","unstructured":"Kelsey WM, Scharyj M: Fatal hepatitis probably due to indomethacin. JAMA 199:586?587, 1967","journal-title":"JAMA"},{"key":"CR138","first-page":"1828","volume":"125","author":"M Kraker-Sangster De","year":"1981","unstructured":"De Kraker-Sangster M, Bronkhorst FB, Brandt K-H, Boersma JW: Massale levercelnecrose na toediening van indometacine in combinatie met aminofenazon. Ned Tijdschr Geneeskd 125:1828?1831, 1981","journal-title":"Ned Tijdschr Geneeskd"},{"key":"CR139","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.3.5558.155","volume":"3","author":"FF Fenech","year":"1967","unstructured":"Fenech FF, Bannister WH, Grech JL: Hepatitis with biliverdinaemia in association with indomethacin therapy. Br Med J 3:155?156, 1967","journal-title":"Br Med J"},{"key":"CR140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-86-4-437","volume":"86","author":"LR Sutherland","year":"1977","unstructured":"Sutherland LR, Edwards LA, Medline A, Wilkinson RW, Connon JJ: Meglumine iodipamide (Cholografin) hepatotoxicity: Ann Intern Med 86:437?439, 1977","journal-title":"Ann Intern Med"},{"key":"CR141","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1055\/s-0028-1104451","volume":"103","author":"K Winckler","year":"1978","unstructured":"Winckler K: Lebernekrosen nach Infusions-Cholangiographie. Dtsch Med Wochenschr 103:420?424, 1978","journal-title":"Dtsch Med Wochenschr"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.12.9.705","volume":"12","author":"AB Ajdukiewicz","year":"1971","unstructured":"Ajdukiewicz AB, Grainger J, Scheuer PJ, Sherlock S: Jaundice due to iprindole. Gut 12:705?708, 1971","journal-title":"Gut"},{"key":"CR143","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0016-5085(78)90856-9","volume":"75","author":"D Pessayre","year":"1978","unstructured":"Pessayre D, De Saint-Louvent P, Degott C, Bernuau J, Rueff B, Benhamou J-P: Iproclozide fulminant hepatitis. Possible role of enzyme induction. Gastroenterology 75:492?496, 1978","journal-title":"Gastroenterology"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM196102092640610","volume":"264","author":"RT Benack","year":"1961","unstructured":"Benack RT, Lynch V: Jaundice associated with isocarboxazid therapy. N Engl J Med 264:294?295, 1961","journal-title":"N Engl J Med"},{"key":"CR145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-3476(80)80213-7","volume":"97","author":"T Bistritzer","year":"1980","unstructured":"Bistritzer T, Barzilay Z, Jonas A: Isoniazid-rifampin-induced fulminant liver disease in an infant. J Pediatr 97:480?482, 1980","journal-title":"J Pediatr"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2008-1040725","volume":"1","author":"WC Maddrey","year":"1981","unstructured":"Maddrey WC: Isoniazid-induced liver disease. Semin Liver Dis 1:129?133, 1981","journal-title":"Semin Liver Dis"},{"key":"CR147","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.1979.03300040039024","volume":"242","author":"WGB Graham","year":"1979","unstructured":"Graham WGB, Dundas GR: Isoniazid-related liver disease. Occurrence with portal hypertension, hypoalbuminemia, and hypersplenism. JAMA 242:353?354, 1979","journal-title":"JAMA"},{"key":"CR148","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-84-2-181","volume":"84","author":"JR Mitchell","year":"1976","unstructured":"Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, Nelson SD: Isoniazid liver injury: Clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med 84:181?192, 1976","journal-title":"Ann Intern Med"},{"key":"CR149","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","volume":"69","author":"M Black","year":"1975","unstructured":"Black M, Mitchell JR, Zimmerman HJ, Ishak KG, Epler GR: Isoniazid-associated hepatitis in 114 patients. Gastroenterology 69:289?302, 1975","journal-title":"Gastroenterology"},{"key":"CR150","first-page":"11","volume":"12","author":"Federal Drug Administration","year":"1982","unstructured":"Federal Drug Administration: Hepatotoxic potential of ketoconazole under investigation. FDA Drug Bull 12:11?12, 1982","journal-title":"FDA Drug Bull"},{"key":"CR151","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bmj.283.6295.825","volume":"283","author":"JK Heiberg","year":"1981","unstructured":"Heiberg JK, Svejgaard E: Toxic hepatitis during ketoconazole treatment. Br Med J 283:825?826, 1981","journal-title":"Br Med J"},{"key":"CR152","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0016-5085(79)80227-9","volume":"76","author":"PF Teychenne","year":"1979","unstructured":"Teychenne PF, Jones EA, Ishak KG, Calne DB: Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: A dopaminergic ergot derivative. Gastroenterology 76:575?583, 1979","journal-title":"Gastroenterology"},{"key":"CR153","first-page":"270","volume":"74","author":"PA Shapiro","year":"1980","unstructured":"Shapiro PA, Antonioli DA, Peppercorn MA: Barbiturate-induced submassive hepatic necrosis. Report of a case and review of the literature. Am J Gastroenterol 74:270?273, 1980","journal-title":"Am J Gastroenterol"},{"key":"CR154","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.1967.00300050085015","volume":"120","author":"EL Krawitt","year":"1967","unstructured":"Krawitt EL, Stein JH, Kirkendall WM, Clifton JA: Mercaptopurine hepatotoxicity in a patient with chronic active hepatitis. Arch Intern Med 120:729?734, 1967","journal-title":"Arch Intern Med"},{"key":"CR155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1651-2227.1978.tb16285.x","volume":"67","author":"JI Bank","year":"1978","unstructured":"Bank JI, Lykkebo D, H\u00e4gerstrand I: Peliosis hepatis in a child. Acta Paediatr Scand 67:105?107, 1978","journal-title":"Acta Paediatr Scand"},{"key":"CR156","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(72)92649-9","volume":"2","author":"FL Johnson","year":"1972","unstructured":"Johnson FL, Feagler JR, Lerner KG, Majerus PW, Siegel M, Hartmann JR, Thomas ED: Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 2:1273?1276, 1972","journal-title":"Lancet"},{"key":"CR157","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.1968.03150080067019","volume":"206","author":"CE Becker","year":"1968","unstructured":"Becker CE, Gorden P, Robbins J: Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos. JAMA 206:1787?1789, 1968","journal-title":"JAMA"},{"key":"CR158","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0190-9622(82)80064-9","volume":"6","author":"HH Roenigk Jr","year":"1982","unstructured":"Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD: Methotrexate guidelines?revised. J Am Acad Dermatol 6:145?155, 1982","journal-title":"J Am Acad Dermatol"},{"key":"CR159","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1001\/jama.1977.03280250057025","volume":"238","author":"FB Ruymann","year":"1977","unstructured":"Ruymann FB, Mosijczuk AD, Sayers RJ: Hepatoma in a child with methotrexate-induced hepatic fibrosis. JAMA 238:2631?2633, 1977","journal-title":"JAMA"},{"key":"CR160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.7326\/0003-4819-80-3-395","volume":"80","author":"PH Joshi","year":"1974","unstructured":"Joshi PH, Conn HO: The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med 80:395?401, 1974","journal-title":"Ann Intern Med"},{"key":"CR161","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2340\/0001555559371372","volume":"59","author":"M Biellerup","year":"1979","unstructured":"Biellerup M, Bruze M, Hansson A, Krook C, Ljunggren B: Liver injury following administration of 8-methoxypsoralen during PUVA therapy. Acta Derm Venereol (Stockh) 59:371?372, 1979","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"CR162","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/00365528109181814","volume":"16","author":"AJ Arranto","year":"1981","unstructured":"Arranto AJ, Sotaniemi EA: Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short-and long-term exposure. Scand J Gastroenterol 16:853?863, 1981","journal-title":"Scand J Gastroenterol"},{"key":"CR163","first-page":"199","volume":"28","author":"M Bal\u00e1zs","year":"1981","unstructured":"Bal\u00e1zs M, Kov\u00e1ch G: Chronic aggressive hepatitis after methyldopa treatment. Case report with electron-microscopic study. Hepato-Gastroenterol 28:199?202, 1981","journal-title":"Hepato-Gastroenterol"},{"key":"CR164","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01071975","volume":"18","author":"AM Hoyumpa Jr","year":"1973","unstructured":"Hoyumpa AM Jr, Connell AM: Methyldopa hepatitis. Report of three cases. Am J Dig Dis 18:213?222, 1973","journal-title":"Am J Dig Dis"},{"key":"CR165","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/BF02239316","volume":"16","author":"JE Tysell Jr","year":"1971","unstructured":"Tysell JE Jr, Knauer CM: Hepatitis induced by methyldopa (Aldomet). Report of a case and a review of the literature. Am J Dig Dis 16:849?855, 1971","journal-title":"Am J Dig Dis"},{"key":"CR166","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/106002808201600607","volume":"16","author":"BD Breland","year":"1982","unstructured":"Breland BD, Hicks GS Jr: Hepatitis and hemolytic anemia associated with methyldopa therapy. Drug Intell Clin Pharm 16:489?492, 1982","journal-title":"Drug Intell Clin Pharm"},{"issue":"Suppl","key":"CR167","first-page":"7","volume":"500","author":"G Brod\u00e9n","year":"1980","unstructured":"Brod\u00e9n G, Bengtsson L: Biliary carcinoma associated with methyldopa therapy. Acta Chir Scand (Suppl)500:7?12, 1980","journal-title":"Acta Chir Scand"},{"key":"CR168","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.1968.03140150074026","volume":"204","author":"GA Glober","year":"1968","unstructured":"Glober GA, Wilkerson JA: Biliary cirrhosis following the administration of methyltestosterone. JAMA 204:170?173, 1968","journal-title":"JAMA"},{"key":"CR169","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2559.1977.tb01663.x","volume":"1","author":"FJ Paradinas","year":"1977","unstructured":"Paradinas FJ, Bull TB, Westaby D, Murray-Lyon IM: Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: Possible relationships of these changes to the development of peliosis hepatis and liver tumours. Histopathology 1:225?246, 1977","journal-title":"Histopathology"},{"key":"CR170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5694\/j.1326-5377.1981.tb113019.x","volume":"2","author":"JR Cocks","year":"1981","unstructured":"Cocks JR: Methyltestosterone-induced liver cell tumours. Med J Aust 2:617?618, 1981","journal-title":"Med J Aust"},{"key":"CR171","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/bjs.1800660324","volume":"66","author":"D Bird","year":"1979","unstructured":"Bird D, Vowles K, Anthony PP: Spontaneous rupture of a liver cell adenoma after long term methyltestosterone: Report of a case successfully treated by emergency right hepatic lobectomy. Br J Surg 66:212?213, 1979","journal-title":"Br J Surg"},{"key":"CR172","first-page":"281","volume":"131","author":"F Fraisse","year":"1980","unstructured":"Fraisse F, Marche C, Gibert C, Coquin Y, Vachon F: N\u00e9crose h\u00e9patique aigu\u00eb et syndrome h\u00e9morragique mortel au d\u00e9cours d'une hypercalc\u00e9mie trait\u00e9e par la mithramycine. Ann Med Intern (Paris) 131:281?284, 1980","journal-title":"Ann Med Intern (Paris)"},{"key":"CR173","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jama.1968.03140250025006","volume":"204","author":"CG Moertel","year":"1968","unstructured":"Moertel CG, Reitemeier RJ, Hahn RG: Mitomycin C therapy in advanced gastrointestinal cancer. JAMA 204:1045?1048, 1968","journal-title":"JAMA"},{"key":"CR174","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0046-8177(82)80008-7","volume":"13","author":"MR Gottfried","year":"1982","unstructured":"Gottfried MR, Sudilovsky O: Hepatic veno-occlusive disease after high-dose mitomycin C and autologous bone marrow transplantation therapy. Hum Pathol 13:646?650, 1982","journal-title":"Hum Pathol"},{"key":"CR175","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/pgmj.56.655.368","volume":"56","author":"RMM Victorino","year":"1980","unstructured":"Victorino RMM, Silveira JCB, Baptista A, De Moura MC: Jaundice associated with naproxen. Postgrad Med J 56:368?370, 1980","journal-title":"Postgrad Med J"},{"key":"CR176","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archinte.1961.03620050019003","volume":"107","author":"WB Parsons Jr","year":"1961","unstructured":"Parsons WB Jr: Studies of nicotinic acid use in hypercholesteremia. Arch Intern Med 107:653?667, 1961","journal-title":"Arch Intern Med"},{"key":"CR177","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(61)90221-2","volume":"31","author":"KG Berge","year":"1961","unstructured":"Berge KG, Achor RWP, Christensen NA, Mason HL, Barker NW: Hypercholesteremia and nicotinic acid. A long-term study. Am J Med 31:24?36, 1961","journal-title":"Am J Med"},{"key":"CR178","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00000441-196908000-00005","volume":"258","author":"RM Kohn","year":"1969","unstructured":"Kohn RM, Montes M: Hepatic fibrosis following long acting nicotinic acid therapy: A case report. Am J Med Sci 258:94?99, 1969","journal-title":"Am J Med Sci"},{"key":"CR179","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-92-1-14","volume":"92","author":"JR Sharp","year":"1980","unstructured":"Sharp JR, Ishak KG, Zimmerman HJ: Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 92:14?19, 1980","journal-title":"Ann Intern Med"},{"key":"CR180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.7326\/0003-4819-92-1-62","volume":"92","author":"M Black","year":"1980","unstructured":"Black M, Rabin L, Schatz N: Nitrofurantoin-induced chronic active hepatitis. Ann Intern Med 92:62?64, 1980","journal-title":"Ann Intern Med"},{"key":"CR181","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01255780","volume":"19","author":"LI Goldstein","year":"1974","unstructured":"Goldstein LI, Ishak KG, Burns W: Hepatic injury associated with nitrofurantoin therapy. Am J Dig Dis 19:987?998, 1974","journal-title":"Am J Dig Dis"},{"key":"CR182","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0016-5085(19)34239-8","volume":"53","author":"S Jokela","year":"1967","unstructured":"Jokela S: Liver disease due to nitrofurantoin. Gastroenterology 53:306?311, 1967","journal-title":"Gastroenterology"},{"key":"CR183","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0090-4295(81)90433-7","volume":"18","author":"PJ Sippel","year":"1981","unstructured":"Sippel PJ, Agger WA: Nitrofurantoin-induced granulomatous hepatitis. Urology 18:177?178, 1981","journal-title":"Urology"},{"key":"CR184","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0954-6820.1982.tb01933.x","volume":"211","author":"H Anttinen","year":"1982","unstructured":"Anttinen H, Ahonen A, Leinonen A, Kallioinen M, Heikkinen ES: Diagnostic imaging of focal nodular hyperplasia of the liver developing during nitrofurantoin therapy. Acta Med Scand 211:227?232, 1982","journal-title":"Acta Med Scand"},{"key":"CR185","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0002-9343(78)90246-2","volume":"64","author":"AH Bruckstein","year":"1978","unstructured":"Bruckstein AH, Attia AA: Oxacillin hepatitis. Two patients with liver biopsy and review of the literature. Am J Med 64:519?522, 1978","journal-title":"Am J Med"},{"issue":"8","key":"CR186","first-page":"138","volume":"191","author":"AT Pas","year":"1965","unstructured":"Pas AT, Quinn EL: Cholestatic hepatitis following the administration of sodium oxacillin. JAMA 191(8):138?139, 1965","journal-title":"JAMA"},{"key":"CR187","first-page":"171","volume":"70","author":"LI Goldstein","year":"1978","unstructured":"Goldstein LI, Granoff M, Waisman J: Hepatic injury due to oxacillin administration. Am J Gastroenterol 70:171?174, 1978","journal-title":"Am J Gastroenterol"},{"key":"CR188","first-page":"213","volume":"71","author":"GL Arnold","year":"1979","unstructured":"Arnold GL, Kaplan MM: Peliosis hepatis due to oxymetholone?a clinically benign disorder. Am J Gastroenterol 71:213?216, 1979","journal-title":"Am J Gastroenterol"},{"key":"CR189","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000182388","volume":"29","author":"D Zevin","year":"1981","unstructured":"Zevin D, Turani H, Cohen A, Levi J: Androgen-associated hepatoma in a hemodialysis patient. Nephron 29:274?276, 1981","journal-title":"Nephron"},{"key":"CR190","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1097-0142(197902)43:2<440::AID-CNCR2820430206>3.0.CO;2-R","volume":"43","author":"FW Stromeyer","year":"1979","unstructured":"Stromeyer FW, Smith DH, Ishak KG: Anabolic steroid therapy and intrahepatic cholangiocarcinoma. Cancer 43:440?443, 1979","journal-title":"Cancer"},{"key":"CR191","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-3476(75)80087-4","volume":"87","author":"JJ Mulvihill","year":"1975","unstructured":"Mulvihill JJ, Ridolfi RL, Schultz FR, Borzy MS, Haughton PBT: Hepatic adenoma in Fanconi anemia treated with oxymetholone. J Pediatr 87:122?124, 1975","journal-title":"J Pediatr"},{"key":"CR192","first-page":"249","volume-title":"Alcoholic Cirrhosis and Other Toxic Hepatopathies","author":"M Lundquist","year":"1970","unstructured":"Lundquist M: Discussion of paper by Sherlock S: Drugs and the liver.In Alcoholic Cirrhosis and Other Toxic Hepatopathies. A Engel, T Larsson (eds.) Stockholm, Nordiska Bokhandelns F\u00f6rlag, 1970, pp 249?250"},{"key":"CR193","first-page":"292","volume":"98","author":"HW Kiaer","year":"1974","unstructured":"Kiaer HW, Olsen S, R\u00f8nnov-Jessen V: Hepatotoxicity of papaverine. Histologic lesions. Arch Pathol 98:292?296, 1974","journal-title":"Arch Pathol"},{"key":"CR194","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/pgmj.56.657.488","volume":"56","author":"MS Pathy","year":"1980","unstructured":"Pathy MS, Reynolds AJ: Papaverine and hepatotoxicity. Postgrad Med J 56:488?490, 1980","journal-title":"Postgrad Med J"},{"key":"CR195","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.1981.03320060076025","volume":"246","author":"CV Multz","year":"1981","unstructured":"Multz CV: Cholestatic hepatitis caused by penicillamine. JAMA 246:674?675, 1981","journal-title":"JAMA"},{"key":"CR196","first-page":"2356","volume":"11","author":"C Job-Deslandre","year":"1982","unstructured":"Job-Deslandre C, Delrieu F, Rondier J, Guedri M, Delbarre F: H\u00e9patite cholestatique et anticorps anti-DNA induits par la D-p\u00e9nicillamine. Nouv Presse Med 11:2356?2357, 1982","journal-title":"Nouv Presse Med"},{"key":"CR197","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF01313594","volume":"26","author":"CN Williams","year":"1981","unstructured":"Williams CN, Malatjalian DA: Severe penicillin-induced cholestasis in a 91-year-old woman. Dig Dis Sci 26:470?473, 1981","journal-title":"Dig Dis Sci"},{"key":"CR198","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/jcp.32.12.1282","volume":"32","author":"GB Forbes","year":"1979","unstructured":"Forbes GB, Rake MO, Taylor DJE: Liver damage due to perhexiline maleate. J Clin Pathol 32:1282?1285, 1979","journal-title":"J Clin Pathol"},{"key":"CR199","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000198433","volume":"20","author":"R Poupon","year":"1980","unstructured":"Poupon R, Rosensztajn L, Prudhomme de Saint Maur P, Lageron A, Gombeau T, Darnis F: Perhexiline maleateassociated hepatic injury prevalence and characteristics. Digestion 20:145?150, 1980","journal-title":"Digestion"},{"key":"CR200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0016-5085(79)80145-6","volume":"76","author":"D Pessayre","year":"1979","unstructured":"Pessayre D, Bichara M, Feldmann G, Degott C, Potet F, Benhamou J-P: Perhexiline maleate-induced cirrhosis. Gastroenterology 76:170?177, 1979","journal-title":"Gastroenterology"},{"key":"CR201","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(82)91475-1","volume":"1","author":"KWG Heathfield","year":"1982","unstructured":"Heathfield KWG, Carabott F: Adverse effects of perhexiline. Lancet 1:507?508, 1982 (letter)","journal-title":"Lancet"},{"key":"CR202","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/BF02231801","volume":"6","author":"D Berkowitz","year":"1961","unstructured":"Berkowitz D, Rotman M, Greenstein RH, Sloane NG: Occurrence of jaundice during treatment with perphenazine and beta-phenylisopropylhydrazine. Am J Dig Dis 6:160?165, 1961","journal-title":"Am J Dig Dis"},{"key":"CR203","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM197205182862007","volume":"286","author":"SE Goldfinger","year":"1972","unstructured":"Goldfinger SE, Marx S: Hypersensitivity hepatitis due to phenazopyridine hydrochloride. N Engl J Med 286:1090?1091, 1972","journal-title":"N Engl J Med"},{"key":"CR204","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(65)90969-4","volume":"1","author":"GC Cook","year":"1965","unstructured":"Cook GC, Sherlock S: Jaundice and its relation to therapeutic agents. Lancet 1:175?179, 1965","journal-title":"Lancet"},{"key":"CR205","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/bmj.1.6179.1679","volume":"1","author":"TK Daneshmend","year":"1979","unstructured":"Daneshmend TK, Scott GL, Bradfield JWB: Angiosarcoma of liver associated with phenelzine. Br Med J 1:1679, 1979","journal-title":"Br Med J"},{"key":"CR206","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0002-9343(53)90376-3","volume":"14","author":"TE McGeachy","year":"1953","unstructured":"McGeachy TE, Bloomer WE: The phenobarbital sensitivity syndrome. Am J Med 14:600?604, 1953","journal-title":"Am J Med"},{"key":"CR207","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0016-5085(69)80099-5","volume":"56","author":"L Pagliaro","year":"1969","unstructured":"Pagliaro L, Campesi G, Aguglia F: Barbiturate jaundice. Report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital. Gastroenterology 56:938?943, 1969","journal-title":"Gastroenterology"},{"key":"CR208","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.1840010311","volume":"1","author":"SB Benjamin","year":"1981","unstructured":"Benjamin SB, Ishak KG, Zimmerman HJ, Grushka A: Phenylbutazone liver injury: A clinical-pathologic survey of 23 cases and review of the literature. Hepatology 1:255?263, 1981","journal-title":"Hepatology"},{"key":"CR209","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000198677","volume":"22","author":"JP Merwe van de","year":"1981","unstructured":"van de Merwe JP, van Blankenstein M, Wilson JHP: Intrahepatic cholestasis induced by phenylbutazone. Digestion 22:317?320, 1981","journal-title":"Digestion"},{"key":"CR210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jama.1954.02950020004002","volume":"156","author":"EP Engleman","year":"1954","unstructured":"Engleman EP, Krupp MA, Rinehart JF, Jones RC, Gibson JR: Hepatitis following the ingestion of phenylbutazone. JAMA 156:98?101, 1954","journal-title":"JAMA"},{"key":"CR211","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(76)80159-X","volume":"70","author":"TJ Lee","year":"1976","unstructured":"Lee TJ, Carney CN, Lapis JL, Higgins T, Fallon HJ: Diphenylhydantoin-induced hepatic necrosis. A case study. Gastroenterology 70:422?424, 1976","journal-title":"Gastroenterology"},{"issue":"12","key":"CR212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jama.1968.03140120013003","volume":"203","author":"U Harinasuta","year":"1968","unstructured":"Harinasuta U, Zimmerman HJ: Diphenylhydantoin sodium hepatitis. JAMA 203(12):111?114, 1968","journal-title":"JAMA"},{"key":"CR213","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-95-4-455","volume":"95","author":"SJ Spechler","year":"1981","unstructured":"Spechler SJ, Sperber H, Doos WG, Koff RS: Cholestasis and toxic epidermal necrolysis associated with phenytoin sodium ingestion: The role of bile duct injury. Ann Intern Med 95:455?456, 1981","journal-title":"Ann Intern Med"},{"key":"CR214","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1445-5994.1981.tb04627.x","volume":"11","author":"IF Cook","year":"1981","unstructured":"Cook IF, Shilkin KB, Reed WD: Phenytoin induced granulomatous hepatitis. Aust NZ J Med 11:539?541, 1981","journal-title":"Aust NZ J Med"},{"key":"CR215","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0016-5085(76)80328-9","volume":"70","author":"AN Hamlyn","year":"1976","unstructured":"Hamlyn AN, Morris JS, Sarkany I, Sherlock S: Piperazine hepatitis. Gastroenterology 70:1144?1147, 1976","journal-title":"Gastroenterology"},{"key":"CR216","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.1.6127.1591","volume":"1","author":"PJE Brown","year":"1978","unstructured":"Brown PJE, Lesna M, Hamlyn AN, Record CO: Primary biliary cirrhosis after long-term practolol administration. Br Med J 1:1591, 1978","journal-title":"Br Med J"},{"key":"CR217","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM195703282561304","volume":"256","author":"ES Reynolds","year":"1957","unstructured":"Reynolds ES, Schlant RC, Gonick HC, Dammin GJ: Fatal massive necrosis of the liver as a manifestation of hypersensitivity to probenecid. N Engl J Med 256:592?596, 1957","journal-title":"N Engl J Med"},{"key":"CR218","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7326\/0003-4819-89-5-646","volume":"89","author":"HH Rotmensch","year":"1978","unstructured":"Rotmensch HH, Yust I, Siegman-Igra Y, Liron M, Ilie B, Vardinon N: Granulomatous hepatitis: A hypersensitivity response to procainamide. Ann Intern Med 89:646?647, 1978","journal-title":"Ann Intern Med"},{"key":"CR219","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/ajcp\/40.3.284","volume":"40","author":"RB McFarland","year":"1963","unstructured":"McFarland RB: Fatal drug reaction associated with prochlorperazine (Compazine). Am J Clin Pathol 40:284?290, 1963","journal-title":"Am J Clin Pathol"},{"key":"CR220","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJM195810162591607","volume":"259","author":"RC Mechanic","year":"1958","unstructured":"Mechanic RC, Meyers L: Chlorpromazine-type cholangitis. Report of a case occurring after the administration of prochlorperazine. N Engl J Med 259:778?780, 1958","journal-title":"N Engl J Med"},{"key":"CR221","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/jama.1959.63010140003011a","volume":"170","author":"A Weinstein","year":"1959","unstructured":"Weinstein A, Alper BJ, Dade JR: Cholestasis due to prochlorperazine. JAMA 170:1663?1664, 1959","journal-title":"JAMA"},{"key":"CR222","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02235094","volume":"16","author":"NC Klein","year":"1971","unstructured":"Klein NC, Magida MG: Propoxyphene (Darvon) hepatotoxicity. Am J Dig Dis 16:467?469, 1971","journal-title":"Am J Dig Dis"},{"key":"CR223","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJM195311122492007","volume":"249","author":"MJ Eisen","year":"1953","unstructured":"Eisen MJ: Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med 249:814?816, 1953","journal-title":"N Engl J Med"},{"key":"CR224","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0016-5085(76)80273-9","volume":"70","author":"AA Mihas","year":"1976","unstructured":"Mihas AA, Holley P, Koff RS, Hirschowitz BI: Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Gastroenterology 70:770?774, 1976","journal-title":"Gastroenterology"},{"key":"CR225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archinte.1975.00330020123017","volume":"135","author":"MS Fedotin","year":"1975","unstructured":"Fedotin MS, Lefer LG: Liver disease caused by propylthiouracil. Arch Intern Med 135:319?321, 1975","journal-title":"Arch Intern Med"},{"key":"CR226","first-page":"199","volume":"6","author":"JC Hutchison","year":"1964","unstructured":"Hutchison JC, Roediger PM, Werblin M: Cholestatic jaundice following administration of quinethazone. Curr Ther Res 6:199?201, 1964","journal-title":"Curr Ther Res"},{"key":"CR227","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0016-5085(76)80326-5","volume":"70","author":"MJ Koch","year":"1976","unstructured":"Koch MJ, Seeff LB, Crumley CE, Rabin L, Burns WA: Quinidine hepatotoxicity. A report of a case and review of the literature. Gastroenterology 70:1136?1140, 1976","journal-title":"Gastroenterology"},{"key":"CR228","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archinte.1980.00330150109025","volume":"140","author":"DA Bramlet","year":"1980","unstructured":"Bramlet DA, Posalaky Z, Olson R: Granulomatous hepatitis as a manifestation of quinidine hypersensitivity. Arch Intern Med 140:395?397, 1980","journal-title":"Arch Intern Med"},{"key":"CR229","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0016-5085(77)80088-7","volume":"72","author":"D Pessayre","year":"1977","unstructured":"Pessayre D, Bentata M, Degott C, Nouel O, Miguet J-P, Rueff B, Benhamou J-P: Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology 72:284?289, 1977","journal-title":"Gastroenterology"},{"key":"CR230","first-page":"371","volume":"130","author":"RY Poupon","year":"1979","unstructured":"Poupon RY, Meyniel D, Petit J, Gustot P, Darnis F: H\u00e9patite cholestatique au cours d'un traitement par l'I.N.H. et la rifampicine: Arguments en faveur de l'h\u00e9patotoxicit\u00e9 de la rifampicine. Ann Med Intern (Paris) 130:371?375, 1979","journal-title":"Ann Med Intern"},{"key":"CR231","doi-asserted-by":"crossref","first-page":"708","DOI":"10.7326\/0003-4819-95-6-708","volume":"95","author":"J Shuck","year":"1981","unstructured":"Shuck J, Shen S, Owensby L, Leftik M, Cucinell S: Spironolactone hepatitis in primary hyperaldosteronism. Ann Intern Med 95:708?710, 1981","journal-title":"Ann Intern Med"},{"key":"CR232","first-page":"777","volume":"75","author":"B Ekl\u00f6f","year":"1978","unstructured":"Ekl\u00f6f B, Gj\u00f6res JE, Lohi A, Norgren L, Staszkiewicz: Spontan ruptur av lever och mj\u00e4lte vid streptokinasbehandling av djup ventrombos. Lakartidningen 75:777?778, 1978","journal-title":"Lakartidningen"},{"key":"CR233","first-page":"94","volume":"40","author":"PA Herbut","year":"1945","unstructured":"Herbut PA, Scaricaciottoli TM: Diffuse hepatic necrosis caused by sulfadiazine. Arch Pathol 40:94?98, 1945","journal-title":"Arch Pathol"},{"key":"CR234","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365521.1974.12096796","volume":"9","author":"M T\u00f6nder","year":"1974","unstructured":"T\u00f6nder M, Nord\u00f6y A, Elgjo K: Sulfonamide-induced chronic liver disease. Scand J Gastroenterol 9:93?96, 1974","journal-title":"Scand J Gastroenterol"},{"key":"CR235","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0016-5085(81)90146-3","volume":"80","author":"DF Ransohoff","year":"1981","unstructured":"Ransohoff DF, Jacobs G: Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology 80:816?819, 1981","journal-title":"Gastroenterology"},{"key":"CR236","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/BF01316868","volume":"26","author":"UP Steinbrecher","year":"1981","unstructured":"Steinbrecher UP, Mishkin S: Sulfamethoxazole-induced hepatic injury. Dig Dis Sci 26:756?759, 1981","journal-title":"Dig Dis Sci"},{"key":"CR237","first-page":"1323","volume":"78","author":"DL Stewart","year":"1980","unstructured":"Stewart DL, Johnson RC: Acute hepatitis caused by sulfamethoxazole-trimethoprim. Gastroenterology 78:1323, 1980 (abstract)","journal-title":"Gastroenterology"},{"key":"CR238","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0016-5085(78)93771-X","volume":"75","author":"RP Sotolongo","year":"1978","unstructured":"Sotolongo RP, Neefe LI, Rudzki C, Ishak KG: Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity: Gastroenterology 75:95?99, 1978","journal-title":"Gastroenterology"},{"key":"CR239","first-page":"1070","volume":"135","author":"JD Losek","year":"1981","unstructured":"Losek JD, Werlin SL: Sulfasalazine hepatotoxicity: Am J Dis Child 135:1070?1072, 1981","journal-title":"Am J Dis Child"},{"key":"CR240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004836-198106000-00017","volume":"3","author":"A Namias","year":"1981","unstructured":"Namias A, Bhalotra R, Donowitz M: Reversible sulfasalazine-induced granulomatous hepatitis. J Clin Gastroenterol 3:193?198, 1981","journal-title":"J Clin Gastroenterol"},{"key":"CR241","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1445-5994.1982.tb02433.x","volume":"12","author":"MD Smith","year":"1982","unstructured":"Smith MD, Gibson GE, Rowland R: Combined hepatotoxicity and neurotoxicity following sulphasalazine administration. Aust NZ J Med 12:76?80, 1982","journal-title":"Aust NZ J Med"},{"key":"CR242","first-page":"703","volume":"22","author":"RH More","year":"1946","unstructured":"More RH, McMillan GC, Duff GL: The pathology of sulfonamide allergy in man. Am J Pathol 22:703?725, 1946","journal-title":"Am J Pathol"},{"key":"CR243","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0025-7125(16)31688-1","volume":"63","author":"HJ Zimmerman","year":"1979","unstructured":"Zimmerman HJ: Drug-induced chronic hepatic disease. Med Clin North Am 63:567?582, 1979","journal-title":"Med Clin North Am"},{"key":"CR244","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0954-6820.1979.tb13498.x","volume":"206","author":"S Iwarson","year":"1979","unstructured":"Iwarson S, Lundin P: Multiple attacks of jaundice associated with repeated sulfonamide treatment. Acta Med Scand 206:219?222, 1979","journal-title":"Acta Med Scand"},{"key":"CR245","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archinte.1982.00340200050013","volume":"142","author":"GD Park","year":"1982","unstructured":"Park GD, Spector R, Headstream T, Goldberg M: Serious adverse reactions associated with sulindac. Arch Intern Med 142:1292?1294, 1982","journal-title":"Arch Intern Med"},{"key":"CR246","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/gut.23.10.875","volume":"23","author":"SJ Whittaker","year":"1982","unstructured":"Whittaker SJ, Amar JN, Wanless IR, Heathcote J: Sulindac hepatotoxicity. Gut 23:875?877, 1982","journal-title":"Gut"},{"key":"CR247","first-page":"334","volume":"25","author":"Y Giroux","year":"1982","unstructured":"Giroux Y, Moreau M, Kass TG: Cholestatic jaundice caused by sulindac. Can J Surg 25:334?335, 1982","journal-title":"Can J Surg"},{"key":"CR248","first-page":"600","volume":"101","author":"GE Sale","year":"1977","unstructured":"Sale GE, Lerner KG: Multiple tumors after androgen therapy. Arch Pathol Lab Med 101:600?603, 1977","journal-title":"Arch Pathol Lab Med"},{"key":"CR249","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4269\/ajtmh.1974.23.676","volume":"23","author":"R Jalota","year":"1974","unstructured":"Jalota R, Freston JW: Severe intrahepatic cholestasis due to thiabendazole. Am J Trop Med Hyg 23:676?678, 1974","journal-title":"Am J Trop Med Hyg"},{"key":"CR250","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-96-1-58","volume":"96","author":"RA Gill","year":"1982","unstructured":"Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW: Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med 96:58?60, 1982","journal-title":"Ann Intern Med"},{"key":"CR251","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/bja\/51.8.801","volume":"51","author":"L Hasselstr\u00f8m","year":"1979","unstructured":"Hasselstr\u00f8m L, Kristoffersen MB: Hepatitis following thiopentone. A case report. Br J Anaesth 51: 801?804, 1979","journal-title":"Br J Anaesth"},{"issue":"10","key":"CR252","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.1966.03110100075018","volume":"197","author":"MJ Reinhart","year":"1966","unstructured":"Reinhart MJ, Benson RM, Kwass SK, Storey WF: Suggestive evidence of hepatotoxicity concomitant with thioridazine hydrochloride use. JAMA 197(10):113?115, 1966","journal-title":"JAMA"},{"key":"CR253","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/00007611-198008000-00035","volume":"73","author":"ME Bridges","year":"1980","unstructured":"Bridges ME, Pittman FE: Tolazamide-induced cholestasis. South Med J 73:1072?1074, 1980","journal-title":"South Med J"},{"key":"CR254","first-page":"81","volume":"69","author":"TA LoIudice","year":"1978","unstructured":"LoIudice TA, Lang JA: Tolazamide-induced hepatic dysfunction. Am J Gastroenterol 69:81?83, 1978","journal-title":"Am J Gastroenterol"},{"key":"CR255","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1749-6632.1959.tb39611.x","volume":"74","author":"LH Hamff","year":"1959","unstructured":"Hamff LH, Ferris HA, Evans EC, Whiteman HW: The effects of tolbutamide and chlorpropamide on patients exhibiting jaundice as a result of previous chlorpropamide therapy. Ann NY Acad Sci 74:820?829, 1959","journal-title":"Ann NY Acad Sci"},{"key":"CR256","first-page":"194","volume":"84","author":"DH Gregory","year":"1967","unstructured":"Gregory DH, Zaki GF, Sarcosi GA, Carey JB Jr: Chronic cholestasis following prolonged tolbutamide administration. Associated with destructive cholangitis and cholangiolitis. Arch Pathol 84:194?201, 1967","journal-title":"Arch Pathol"},{"key":"CR257","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jama.1964.03060340050015","volume":"188","author":"C Bandt","year":"1964","unstructured":"Bandt C, Hoffbauer FW: Liver injury associated with tranylcypromine therapy. JAMA 188:752?753, 1964","journal-title":"JAMA"},{"key":"CR258","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/pgmj.57.673.730","volume":"57","author":"I Cobden","year":"1981","unstructured":"Cobden I, Record CO, White RWB: Fatal intrahepatic cholestasis associated with triazolam. Postgrad Med J 57:730?731, 1981","journal-title":"Postgrad Med J"},{"key":"CR259","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM196103162641107","volume":"264","author":"N Kohn","year":"1961","unstructured":"Kohn N, Myerson RM: Cholestatic hepatitis associated with trifluoperazine. N Engl J Med 264:549?550, 1961","journal-title":"N Engl J Med"},{"key":"CR260","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archinte.1967.00300030113023","volume":"120","author":"I Borda","year":"1967","unstructured":"Borda I, Jick H: Hepatitis following the administration of trimethobenzamide hydrochloride. Arch Intern Med 120:371?373, 1967","journal-title":"Arch Intern Med"},{"key":"CR261","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00007611-198107000-00035","volume":"74","author":"H Coto","year":"1981","unstructured":"Coto H, McGowan WR, Pierce EH Jr, Thomas E: Intrahepatic cholestasis due to trimethoprim-sulfamethoxazole. South Med J 74:897?898, 1981","journal-title":"South Med J"},{"key":"CR262","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.0954-6820.1967.tb10873.x","volume":"182","author":"M Bj\u00f8rneboe","year":"1967","unstructured":"Bj\u00f8rneboe M, Iversen O, Olsen S: Infective hepatitis and toxic jaundice in a municipal hospital during a five-year period. Incidence and prognosis. Acta Med Scand 182:491?501, 1967","journal-title":"Acta Med Scand"},{"key":"CR263","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","volume":"2","author":"HJ Zimmerman","year":"1982","unstructured":"Zimmerman HJ, Ishak KG: Valproate-induced hepatic injury: Analyses of 23 fatal cases. Hepatology 2:591?597, 1982","journal-title":"Hepatology"},{"key":"CR264","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archsurg.1979.01370300088017","volume":"114","author":"H Dizadji","year":"1979","unstructured":"Dizadji H, Hammer R, Strzyz B, Weisenberger J: Spontaneous rupture of the liver. A complication of oral anticoagulant therapy. Arch Surg 114:734?735, 1979","journal-title":"Arch Surg"},{"key":"CR265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.0954-6820.1978.tb08449.x","volume":"204","author":"N Rehnqvist","year":"1978","unstructured":"Rehnqvist N: Intrahepatic jaundice due to warfarin therapy. Acta Med Scand 204:335?336, 1978","journal-title":"Acta Med Scand"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01299927.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01299927\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01299927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T08:33:35Z","timestamp":1706085215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01299927"}},"subtitle":["An updated tabular compilation of drugs and drug-related hepatic diseases"],"short-title":[],"issued":{"date-parts":[[1983,7]]},"references-count":265,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1983,7]]}},"alternative-id":["BF01299927"],"URL":"https:\/\/doi.org\/10.1007\/bf01299927","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,7]]}}}